文献速递脑血管病外科神经重症

载脂蛋白E基因型在动脉瘤性蛛网膜下腔出血中的作用:易感性、并发症与预后

Role of Apolipoprotein E Genotypes in Aneurysmal Subarachnoid Hemorrhage: Susceptibility, Complications, and Prognosis.
PubMed 文献 · World Neurosurg · 2018-08-12

这项Meta分析纳入18项研究,评估载脂蛋白E(ApoE)基因型与动脉瘤性蛛网膜下腔出血(aSAH)易感性、并发症及预后的关系。结果发现ε4携带者aSAH风险升高(OR 1.23,95%CI 1.01-1.49),ε4携带者不良预后风险升高(OR 2.21,95%CI 1.21-4.05),但ApoE基因型与入院严重程度、再出血或脑血管痉挛无显著差异。

要点

  • ε4携带者aSAH风险升高(OR 1.23,95%CI 1.01-1.49)。
  • 白色人种ε2/ε2基因型aSAH风险更高(OR 3.38,95%CI 1.13-10.11)。
  • ε4携带者不良预后风险升高(OR 2.21,95%CI 1.21-4.05),亚洲患者更明显(OR 4.99,95%CI 1.73-14.40)。

核心结论

  • ApoE基因型与aSAH风险显著相关,但其在某些种族人群中的效应存在差异。
  • 携带ε4等位基因的患者可能有更差的预后,而当前证据不足以证明ApoE基因型与SAH后并发症的关联。

研究设计与样本

  • 检索PubMed、Embase、中国知网和万方数据库中关于ApoE基因型与aSAH的研究,最终纳入18项研究进行Meta分析。

主要发现

  • ε4携带者aSAH风险升高(OR 1.23,95%CI 1.01-1.49)。
  • 白色人种ε2/ε2基因型aSAH风险更高(OR 3.38,95%CI 1.13-10.11)。
  • aSAH患者中ε4携带者较非ε4携带者不良预后风险升高(OR 2.21,95%CI 1.21-4.05),亚洲患者中更明显(OR 4.99,95%CI 1.73-14.40)。
  • 总体人群中,ApoE ε4携带者较非ε4携带者迟发性缺血性神经功能缺损风险升高。
  • 特定ApoE基因型对aSAH入院严重程度、再出血或脑血管痉挛的影响无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating disease. Emerging evidence has indicated that the apolipoprotein E (ApoE) genotype might be associated with the risk of aSAH as well as complications and outcomes after aSAH, although the results remain controversial. METHODS: We searched published literature on PubMed, Embase, China National Knowledge Infrastructure, and Wanfang database to identify studies involving the ApoE genotype and aSAH. A meta-analysis was performed to summarize the relationship between ApoE genotype and aSAH, including susceptibility, complications, and prognosis. RESULTS: Eighteen studies were considered eligible for inclusion. Generally, ε4 carriers had increased risk of aSAH (odds ratio [OR] 1.23, 95% confidence interval [CI] 1.01-1.49). White patients with the ε2/ε2 genotype had a greater risk of aSAH (OR 3.38, 95% CI 1.13-10.11). The patients with aSAH carrying the ε4 allele had an increased risk of poor outcome (OR 2.21, 95% CI 1.21-4.05) compared with non-ε4 carriers, especially in Asian patients (OR 4.99, 95% CI 1.73-14.40). ApoE ε4 carriers have increased risk of delayed ischemic neurologic deficit compared with non-ε4 carriers in the overall population. No significant difference was detected regarding the effect of certain ApoE genotypes on aSAH admission severity, rebleeding, or cerebral vasospasm after aSAH. CONCLUSIONS: We found that the ApoE genotype was significantly associated with aSAH risk, whereas its effect on certain ethnic populations differs. Patient carrying the ε4 allele might have a worse outcome, whereas current evidence was insufficient to prove the association between ApoE genotypes and post-SAH complications.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hu X, Xie Z, Zan X, et al. Role of Apolipoprotein E Genotypes in Aneurysmal Subarachnoid Hemorrhage: Susceptibility, Complications, and Prognosis. World Neurosurg. 2018. PMID: 30010064. doi:10.1016/j.wneu.2018.07.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。